Bacitracin/hydrocortisone/neomycin/polymyxin b topical Interactions
There are 68 drugs known to interact with bacitracin/hydrocortisone/neomycin/polymyxin b topical, along with 7 disease interactions. Of the total drug interactions, 68 are moderate.
- View all 68 medications that may interact with bacitracin/hydrocortisone/neomycin/polymyxin b topical
- View bacitracin/hydrocortisone/neomycin/polymyxin b topical disease interactions (7)
Most frequently checked interactions
View interaction reports for bacitracin / hydrocortisone / neomycin / polymyxin b topical and the medicines listed below.
- Ativan (lorazepam)
- Atrovent HFA (ipratropium)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- BuSpar (buspirone)
- Celexa (citalopram)
- Clotrimazole Troche (clotrimazole)
- Daliresp (roflumilast)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Flovent HFA (fluticasone)
- Klor-Con M20 (potassium chloride)
- L-Carnitine (levocarnitine)
- MiraLAX (polyethylene glycol 3350)
- Pepto-Bismol (bismuth subsalicylate)
- Percocet (acetaminophen / oxycodone)
- Percocet 5 / 325 (acetaminophen / oxycodone)
- ProAir HFA (albuterol)
- Rozerem (ramelteon)
- Symbicort (budesonide / formoterol)
- Travatan Z (travoprost ophthalmic)
- Vitamin D3 (cholecalciferol)
- Voltaren Arthritis Pain Gel (diclofenac topical)
Bacitracin/hydrocortisone/neomycin/polymyxin b topical disease interactions
There are 7 disease interactions with bacitracin / hydrocortisone / neomycin / polymyxin b topical which include:
- perforated tympanic membrane
- burns
- diabetes
- diaper rash
- hyperadrenocorticism
- infections
- ocular toxicities
Report options
QR code containing a link to this page
More about bacitracin / hydrocortisone / neomycin / polymyxin b topical
- bacitracin/hydrocortisone/neomycin/polymyxin b topical consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.